跳至主導覽 跳至搜尋 跳過主要內容

Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer

  • Pei Hung Chang
  • , Yi Ping Pan
  • , Chung Wei Fan
  • , Wen Ko Tseng
  • , Jen Seng Huang
  • , Tsung Han Wu
  • , Wen Chi Chou
  • , Cheng Hsu Wang
  • , Kun Yun Yeh*
  • *此作品的通信作者
  • Chang Gung University

研究成果: 期刊稿件 › 文章 › 同儕審查

62 引文 斯高帕斯(Scopus)

摘要

The correlations of pretreatment serum concentrations of proinflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNFα) with the clinicopathologic features and progression of colorectal cancer (CRC) were investigated. The pretreatment serum levels of IL-1β, IL-6, and TNFα were measured in 164 CRC patients before treatment. The relationships between changes in proinflammatory cytokine and C-reactive protein (CRP) levels and both clinicopathologic variables and disease progression were examined by univariate and multivariate analysis. Advanced tumor stage was associated with a poorer histologic differentiation, higher CRP level, lower albumin level, and inferior progression-free survival rate (PFSR). Furthermore, high levels of CRP (>5 mg/L) were associated with proinflammatory cytokine intensity, defined according to the number of proinflammatory cytokines with levels above the median level (IL-1β ≥10 pg/mL; IL-6 ≥ 10 pg/mL; and TNFα ≥55 pg/mL). Under different inflammation states, proinflammatory cytokine intensity, in addition to tumor stage, independently predicted PFSR in patients with CRP <5 mg/L, whereas tumor stage was the only independent predictor of PFSR in patients with CRP ≥5 mg/L. Proinflammatory cytokine intensity and the CRP level are clinically relevant for CRC progression. Measurement of IL-1β, IL-6, and TNFα serum levels may help identify early cancer progression among patients with CRP <5 mg/L in routine practice.

原文英語
頁(從 - 到)426-433
頁數8
期刊Cancer Medicine
卷5
發行號3
DOIs
出版品狀態已出版 - 01 03 2016

文獻附註

Publisher Copyright:
© 2016 Published by John Wiley & Sons Ltd.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer」主題。共同形成了獨特的指紋。

引用此